These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
555 related items for PubMed ID: 24290372
1. MicroRNA-30a-3p inhibits tumor proliferation, invasiveness and metastasis and is downregulated in hepatocellular carcinoma. Wang W, Lin H, Zhou L, Zhu Q, Gao S, Xie H, Liu Z, Xu Z, Wei J, Huang X, Zheng S. Eur J Surg Oncol; 2014 Nov; 40(11):1586-94. PubMed ID: 24290372 [Abstract] [Full Text] [Related]
2. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN. Zhang QY, Men CJ, Ding XW. J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454 [Abstract] [Full Text] [Related]
3. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway. Li WF, Dai H, Ou Q, Zuo GQ, Liu CA. Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417 [Abstract] [Full Text] [Related]
4. miR-27a-3p suppresses tumor metastasis and VM by down-regulating VE-cadherin expression and inhibiting EMT: an essential role for Twist-1 in HCC. Zhao N, Sun H, Sun B, Zhu D, Zhao X, Wang Y, Gu Q, Dong X, Liu F, Zhang Y, Li X. Sci Rep; 2016 Mar 16; 6():23091. PubMed ID: 26980408 [Abstract] [Full Text] [Related]
5. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL, Wang WY, Yao WQ, Li GD. Int J Mol Med; 2015 Dec 16; 36(6):1713-9. PubMed ID: 26499886 [Abstract] [Full Text] [Related]
6. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY, Zhang K, Chen DQ, Chen J, Feng B, Song H, Chen Y, Zhu Z, Lu L, De W, Wang R, Chen LB. Oncotarget; 2015 Jul 30; 6(21):18613-30. PubMed ID: 26164082 [Abstract] [Full Text] [Related]
7. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell. Hou X, Yang L, Jiang X, Liu Z, Li X, Xie S, Li G, Liu J. Int J Biol Macromol; 2019 May 01; 128():331-339. PubMed ID: 30695725 [Abstract] [Full Text] [Related]
8. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. Guo Y, Yao B, Zhu Q, Xiao Z, Hu L, Liu X, Li L, Wang J, Xu Q, Yang L, Huang D. J Cell Mol Med; 2019 Aug 01; 23(8):5037-5047. PubMed ID: 31207037 [Abstract] [Full Text] [Related]
9. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma. Wu G, Zheng K, Xia S, Wang Y, Meng X, Qin X, Cheng Y. J Exp Clin Cancer Res; 2016 Jun 04; 35(1):89. PubMed ID: 27259866 [Abstract] [Full Text] [Related]
10. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9. Yao B, Li Y, Wang L, Chen T, Niu Y, Liu Q, Liu Z. Artif Cells Nanomed Biotechnol; 2019 Dec 04; 47(1):3885-3895. PubMed ID: 31561723 [Abstract] [Full Text] [Related]
11. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells. Shi Y, Yan F, Wang F, Pan L. Tissue Cell; 2021 Oct 04; 72():101534. PubMed ID: 33991762 [Abstract] [Full Text] [Related]
12. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. Song LN, Qiao GL, Yu J, Yang CM, Chen Y, Deng ZF, Song LH, Ma LJ, Yan HL. J Exp Clin Cancer Res; 2020 Jun 17; 39(1):114. PubMed ID: 32552766 [Abstract] [Full Text] [Related]
13. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A. Cui S, Zhang K, Li C, Chen J, Pan Y, Feng B, Lu L, Zhu Z, Wang R, Chen L. Oncotarget; 2016 Nov 22; 7(47):78009-78028. PubMed ID: 27793005 [Abstract] [Full Text] [Related]
14. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis. Yao Z, Xiong Z, Li R, Liang H, Jia C, Deng M. Biomed Pharmacother; 2018 Aug 22; 104():102-109. PubMed ID: 29772429 [Abstract] [Full Text] [Related]
15. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma]. Xu Q, Cai W, Zhang M, Liu Q, Liu X. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar 22; 32(3):387-92. PubMed ID: 26927562 [Abstract] [Full Text] [Related]
16. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C. Tao J, Liu Z, Wang Y, Wang L, Yao B, Li Q, Wang C, Tu K, Liu Q. Biomed Pharmacother; 2017 Sep 22; 93():420-428. PubMed ID: 28666208 [Abstract] [Full Text] [Related]
17. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma. Pan Y, Tong S, Cui R, Fan J, Liu C, Lin Y, Tang J, Xie H, Lin P, Zheng T, Yu X. Cell Physiol Biochem; 2018 Sep 22; 50(1):108-120. PubMed ID: 30278452 [Abstract] [Full Text] [Related]
18. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway. Jin Y, Wang J, Han J, Luo D, Sun Z. Exp Cell Res; 2017 Nov 15; 360(2):210-217. PubMed ID: 28890291 [Abstract] [Full Text] [Related]
19. Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation. Lou W, Chen J, Ding B, Chen D, Zheng H, Jiang D, Xu L, Bao C, Cao G, Fan W. J Transl Med; 2018 Sep 29; 16(1):266. PubMed ID: 30268144 [Abstract] [Full Text] [Related]
20. MicroRNA-1277 Inhibits Proliferation and Migration of Hepatocellular Carcinoma HepG2 Cells by Targeting and Suppressing BMP4 Expression and Reflects the Significant Indicative Role in Hepatocellular Carcinoma Pathology and Diagnosis After Magnetic Resonance Imaging Assessment. Cao X, Xu L, Liu Q, Yang L, Li N, Li X. Oncol Res; 2019 Feb 21; 27(3):301-309. PubMed ID: 29562958 [Abstract] [Full Text] [Related] Page: [Next] [New Search]